IMPRIMIS PHARMACEUTICALS INC's ticker is IMMY and the CUSIP is 45323A201. A total of 20 filers reported holding IMPRIMIS PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $14,000 | +16.7% | 2,510 | -32.6% | 0.00% | 0.0% |
| Q2 2017 | $12,000 | +300.0% | 3,724 | +351.4% | 0.00% | – |
| Q3 2016 | $3,000 | +50.0% | 825 | +50.5% | 0.00% | – |
| Q2 2016 | $2,000 | 0.0% | 548 | -3.9% | 0.00% | – |
| Q1 2016 | $2,000 | -50.0% | 570 | -1.0% | 0.00% | -100.0% |
| Q4 2015 | $4,000 | -80.0% | 576 | -81.1% | 0.00% | -50.0% |
| Q3 2015 | $20,000 | +1900.0% | 3,054 | +2865.0% | 0.00% | – |
| Q2 2015 | $1,000 | -75.0% | 103 | -77.6% | 0.00% | – |
| Q1 2015 | $4,000 | +100.0% | 460 | +98.3% | 0.00% | – |
| Q4 2014 | $2,000 | -85.7% | 232 | -88.6% | 0.00% | -100.0% |
| Q1 2014 | $14,000 | +7.7% | 2,039 | -46.6% | 0.00% | 0.0% |
| Q4 2013 | $13,000 | +225.0% | 3,818 | +350.2% | 0.00% | – |
| Q3 2013 | $4,000 | – | 848 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|